Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McClellan on supplements

This article was originally published in The Tan Sheet

Executive Summary

FDA expects to finalize its proposed rule establishing dietary supplement GMPs "next year," Commissioner Mark McClellan, MD/PhD, states at the Consumer Healthcare Products Association's Annual Executive Conference in Aventura, Fla. March 14. The agency published the proposal in the March 13 Federal Register (1"The Tan Sheet" March 10, 2003, p. 3). McClellan notes FDA also will "aggressively" target dietary supplements making not only unapproved disease claims, but also "claims that are not supported about structure and function impacts"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095259

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel